EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer-Reference-Cited by-同舟云学术

EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

Published:2003-11 Issue:5 Volume:115 Page:523-535
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Hughes-Davies Luke,Huntsman David,Ruas Margarida,Fuks Francois,Bye Jacqueline,Chin Suet-Feung,Milner Jonathon,Brown Lindsay A,Hsu Forrest,Gilks Blake,Nielsen Torsten,Schulzer Michael,Chia Stephen,Ragaz Joseph,Cahn Anthony,Linger Lori,Ozdag Hilal,Cattaneo Elena,Jordanova E.S,Schuuring Edward,Yu David S,Venkitaraman Ashok,Ponder Bruce,Doherty Aidan,Aparicio Samuel,Bentley David,Theillet Charles,Ponting Chris P,Caldas Carlos,Kouzarides Tony

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference37 articles.

1. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif;Ansieau;J. Biol. Chem.,2002

2. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin;Bachman;J. Biol. Chem.,2001

3. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain;Bannister;Nature,2001

4. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma;Bekri;Cytogenet. Cell Genet.,1997

5. BRCA1 is associated with a human SWI/SNF-related complex;Bochar;Cell,2000

Cited by 362 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supervised learning of enhancer–promoter specificity based on genome-wide perturbation studies highlights areas for improvement in learning;Bioinformatics;2024-06

2. Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification;JAAD Case Reports;2024-06

3. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer;Cell Reports Medicine;2024-02

4. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?;Cancer Treatment Reviews;2023-12

5. Machine learning of enhancer-promoter specificity based on enhancer perturbation studies reveals a distinct class of enhancers;2023-06-30